Summary COVID-19-associated pulmonary mucormycosis (CAPM) remains an
underdiagnosed entity. Using a modified Delphi method, we have formulated a consensus …

Mucormycosis, a secondary fungal infection, gained much attention in the ongoing COVID-
19 pandemic. This deadly infection has a high all-cause mortality rate and imposes a …

Abstract Introduction: Invasive fungal infections (IFIs) in Asia/Pacific are a particular threat to
patients with malignancies, uncontrolled diabetes mellitus or undiagnosed/untreated human …

Background Mucormycosis is a deadly invasive fungal infection recently included in the
WHO priority pathogen list. Here we sought to describe epidemiological trends of …

The recent increase of COVID-19-associated mucormycosis (CAM) has been commanding
global attention. However, basic epidemiologic characteristics have not firmly been …

Resistance in micro-organisms against antimicrobial compounds is an emerging
phenomenon in the modern era as compared to the traditional world which brings new …

Background Most COVID‐19‐associated mucormycosis (CAM) cases are reported from
India and neighbouring countries. Anecdotally cases from Europe have been presented …

An unprecedented mucormycosis outbreak occurred in India during the second COVID-19
wave in spring 2021. COVID-19-associated mucormycosis (CAM) was observed, mainly …

Background An unprecedented rise in the number of COVID-19-associated mucormycosis
(CAM) cases has been reported in India. Myriad hypotheses are proposed for the outbreak …

This work aimed to prepare ketoconazole-loaded ethosomes and binary ethosomes to
improve its skin delivery and antifungal efficacy. A 3 2 factorial design was used to optimize …